Optiquel Uses, Dosage, Side Effects and more
Optiquel is under investigation in clinical trial NCT01195948 (Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis).
| Trade Name | Optiquel |
| Generic | B27PD |
| B27PD Other Names | Alnedlsswtaadt, Optiquel, Peptide b27pd |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
